Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.3.2023STADA Arzneimittel AG (STD)5839CKyselina zoledrónová STADA 5 mg/100 ml infúzny roztok (sol inf 1x100 ml/5 mg (liek.inj.skl.))14.3.2023U
 20.3.2023STADA Arzneimittel AG (STD)6442BAripiprazol STADA 15 mg orodispergovateľné tablety (tbl oro 28x15 mg (blis.OPA/Al/PVC/Al))20.3.2023O
 20.3.2023PharmaSwiss Česká republika s.r.o. (PRW)53128Cefzil 250 mg/5 ml (plu por 1x3 g (fľ.HDPE))21.3.2023R
 20.3.2023Novartis Europharm Limited (NEH-IE)35207DuoTrav 40 mikrogramov/ml + 5 mg/ml očná roztoková instilácia (int opo 3x2,5 ml (40 µg/ml+5 mg/ml) (fľ.PP))21.3.2023O
 20.3.2023STADA Arzneimittel AG (STD)9257AEplerenon STADA 50 mg filmom obalené tablety (tbl flm 100x50 mg (blis.PVC/Al))17.3.2023O
 19.3.2023Vipharm S.A. (VIH-PL-1)07348Letrovena 2,5 mg filmom obalené tablety (tbl flm 100x2,5 mg (blis.PVC/Al))20.3.2023R
 18.3.2023Jazz Pharmaceuticals Ireland Ltd (JAZ)9533CVyxeos liposomal 44 mg/100 mg prášok na koncentrát na infúzny roztok (plc ifc 1x44 mg/100 mg (liek.inj.skl.))20.2.2023U
 17.3.2023CSL Behring GmbH (CSL)88206Alburex 20 (sol inf 1x100 ml/20 g (liek.skl.inj.))16.3.2023R
 17.3.2023G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))15.3.2023O
 17.3.2023Pfizer Europe MA EEIG (PFI-BE-3)94882SOLU-MEDROL 250 mg (plv iol 1x250 mg+4 ml solv. (1x dvojkomorová Act-O-Vial))21.3.2023Z
 16.3.2023POLICHEM S.A. (PLC)41145MACMIROR COMPLEX (crm vag 1x30 g (tuba Al))15.3.2023O
 16.3.2023Angelini Pharma Österreich GmbH (ANG-AT-1)7757AGlimbax (aer ora 1x15 ml (fľ.skl.hnedá))15.3.2023O
 16.3.2023Merck Sharp & Dohme B.V. (MSD-NL)40775CANCIDAS 70 mg prášok na infúzny koncentrát (plc ifc 1x70 mg (liek.inj.skl.))20.5.2023Z
 16.3.2023Merck Sharp & Dohme B.V. (MSD-NL)40776CANCIDAS 50 mg prášok na infúzny koncentrát (plc ifc 1x50 mg (liek.inj.skl.))20.5.2023Z
 16.3.2023Angelini Pharma Česká republika s.r.o. (AIP-2)28993ERDOMED 3,5 % (plu por 1x50 g (fľ.skl.jantárová))22.2.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To